TY - JOUR
T1 - Post-cardiac arrest PCI is underutilized among cancer patients
T2 - Machine learning augmented nationally representative case-control study of 30 million hospitalizations
AU - Kim, Jin wan
AU - Monlezun, Dominique
AU - Park, Jong kun
AU - Chauhan, Siddharth
AU - Balanescu, Dinu
AU - Koutroumpakis, Efstratios
AU - Palaskas, Nicolas
AU - Kim, Peter
AU - Hassan, Saamir
AU - Botz, Gregory
AU - Crommett, John
AU - Reddy, Dereddi
AU - Cilingiroglu, Mehmet
AU - Marmagkiolis, Konstantinos
AU - Iliescu, Cezar
N1 - Publisher Copyright:
© 2022
PY - 2022/10
Y1 - 2022/10
N2 - Background: Cancer patients are less likely to undergo percutaneous coronary intervention (PCI) after cardiac arrest, although they demonstrate improved mortality benefit from the procedure. We produced the largest nationally representative analysis of mortality of cardiac arrest and PCI for patients with cancer versus non-cancer. Methods: Propensity score adjusted multivariable regression for mortality was performed in this case-control study of the United States’ largest all-payer hospitalized dataset, the 2016 National Inpatient Sample. Regression models of mortality and PCI weighted by the complex survey design were fully adjusted for age, race, income, cancer metastases, NIS-calculated mortality risk by Diagnosis Related Group (DRG), acute coronary syndrome, and likelihood of undergoing PCI. Results: Of the 30,195,722 hospitalized adult patients, 15.43% had cancer, and 0.79% of the whole sample presented with cardiac arrest (of whom 20.57% underwent PCI). In fully adjusted regression analysis among patients with cardiac arrest, PCI significantly reduced mortality (OR 0.15, 95 %CI 0.13–0.19; p < 0.001) among patients with cancer greater than those without it (OR 0.21, 95 %CI 0.20–0.23; p < 0.001). Conclusions: This nationally representative study suggests that post-cardiac arrest PCI is underutilized among patients with cancer despite its significant mortality reduction for such patients (independent of clinical acuity).
AB - Background: Cancer patients are less likely to undergo percutaneous coronary intervention (PCI) after cardiac arrest, although they demonstrate improved mortality benefit from the procedure. We produced the largest nationally representative analysis of mortality of cardiac arrest and PCI for patients with cancer versus non-cancer. Methods: Propensity score adjusted multivariable regression for mortality was performed in this case-control study of the United States’ largest all-payer hospitalized dataset, the 2016 National Inpatient Sample. Regression models of mortality and PCI weighted by the complex survey design were fully adjusted for age, race, income, cancer metastases, NIS-calculated mortality risk by Diagnosis Related Group (DRG), acute coronary syndrome, and likelihood of undergoing PCI. Results: Of the 30,195,722 hospitalized adult patients, 15.43% had cancer, and 0.79% of the whole sample presented with cardiac arrest (of whom 20.57% underwent PCI). In fully adjusted regression analysis among patients with cardiac arrest, PCI significantly reduced mortality (OR 0.15, 95 %CI 0.13–0.19; p < 0.001) among patients with cancer greater than those without it (OR 0.21, 95 %CI 0.20–0.23; p < 0.001). Conclusions: This nationally representative study suggests that post-cardiac arrest PCI is underutilized among patients with cancer despite its significant mortality reduction for such patients (independent of clinical acuity).
KW - Cancer
KW - Cardiac Arrest
KW - Cardiooncology
KW - Percutaneous Coronary Intervention
UR - http://www.scopus.com/inward/record.url?scp=85135845556&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135845556&partnerID=8YFLogxK
U2 - 10.1016/j.resuscitation.2022.07.032
DO - 10.1016/j.resuscitation.2022.07.032
M3 - Article
C2 - 35933056
AN - SCOPUS:85135845556
SN - 0300-9572
VL - 179
SP - 43
EP - 49
JO - Resuscitation
JF - Resuscitation
ER -